Front Barnett Associates’s Pfizer PFE Stock Holding History

Front Barnett Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$388K	Sell	11,704 -60	-0.5%	-$2.12K	0.05%	89
2023 Q2	$432K	Sell	11,764 -25	-0.2%	-$973	0.05%	88
2023 Q1	$481K	Hold	11,789	–	–	0.06%	86
2022 Q4	$604K	Sell	11,789 -30	-0.3%	-$1.44K	0.08%	79
2022 Q3	$517K	Hold	11,819	–	–	0.07%	83
2022 Q2	$620K	Hold	11,819	–	–	0.08%	83
2022 Q1	$612K	Sell	11,819 -191	-2%	-$9.91K	0.06%	81
2021 Q4	$709K	Hold	12,010	–	–	0.07%	80
2021 Q3	$517K	Sell	12,010 -166	-1%	-$7.35K	0.05%	89
2021 Q2	$477K	Sell	12,176 -166	-1%	-$6.46K	0.05%	90
2021 Q1	$447K	Hold	12,342	–	–	0.05%	86
2020 Q4	$454K	Sell	12,342 -666	-5%	-$24.4K	0.05%	82
2020 Q3	$453K	Buy	13,008 +316	+2%	+$11.1K	0.06%	78
2020 Q2	$394K	Sell	12,692 -2	-0%	-$68	0.06%	86
2020 Q1	$393K	Buy	12,694 +527	+4%	+$18K	0.08%	86
2019 Q4	$452K	Hold	12,167	–	–	0.07%	89
2019 Q3	$415K	Sell	12,167 -211	-2%	-$7.67K	0.07%	90
2019 Q2	$509K	Sell	12,378 -1,617	-12%	-$64.2K	0.09%	85
2019 Q1	$564K	Buy	13,995 +795	+6%	+$31.8K	0.09%	85
2018 Q4	$547K	Sell	13,200 -917	-6%	-$38.1K	0.1%	81
2018 Q3	$590K	Sell	14,117 -404	-3%	-$15.6K	0.09%	81
2018 Q2	$500K	Hold	14,521	–	–	0.08%	84
2018 Q1	$489K	Sell	14,521 -181	-1%	-$6.22K	0.08%	84
2017 Q4	$505K	Hold	14,702	–	–	0.08%	85
2017 Q3	$498K	Hold	14,702	–	–	0.09%	85
2017 Q2	$469K	Hold	14,702	–	–	0.09%	89
2017 Q1	$477K	Hold	14,702	–	–	0.09%	87
2016 Q4	$453K	Sell	14,702 -79	-0.5%	-$2.41K	0.09%	87
2016 Q3	$475K	Hold	14,781	–	–	0.09%	85
2016 Q2	$494K	Buy	14,781 +738	+5%	+$23.6K	0.1%	83
2016 Q1	$395K	Hold	14,043	–	–	0.08%	90
2015 Q4	$430K	Hold	14,043	–	–	0.09%	86
2015 Q3	$419K	Hold	14,043	–	–	0.09%	83
2015 Q2	$447K	Buy	14,043 +1,054	+8%	+$34.4K	0.08%	82
2015 Q1	$429K	Buy	12,989 +3,010	+30%	+$95.7K	0.08%	83
2014 Q4	$295K	Buy	9,979 +513	+5%	+$14.7K	0.06%	97
2014 Q3	$266K	Sell	9,466 -81	-0.8%	-$2.27K	0.05%	103
2014 Q2	$269K	Sell	9,547 -53	-0.6%	-$1.51K	0.05%	99
2014 Q1	$293K	Sell	9,600 -124	-1%	-$3.7K	0.06%	91
2013 Q4	$283K	Sell	9,724 -148	-1%	-$4.31K	0.06%	93
2013 Q3	$269K	Buy	9,872 +148	+2%	+$4.03K	0.06%	93
2013 Q2	$258K	Buy	+9,724	New	+$269K	0.06%	92

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Front Barnett Associates's PFE Position: Q3 2023 in Review

Front Barnett Associates reduced its Pfizer (PFE) stake by 0.51% in Q3 2023, selling an estimated $2.12K and leaving 11,704 shares worth $388K. The position accounts for 0.05% of the portfolio, ranked #89.

Front Barnett Associates first reported a position in PFE in Q2 2013 and has held it in 42 quarters since. The position peaked at $709K in Q4 2021. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Front Barnett Associates held 11,704 shares of Pfizer worth $388K as of Q3 2023.
Front Barnett Associates sold 60 Pfizer shares in Q3 2023, an estimated $2.12K.
Pfizer made up 0.05% of Front Barnett Associates's portfolio in Q3 2023, its #89 holding.
Front Barnett Associates first reported a position in Pfizer in Q2 2013 and has held it in 42 quarters since.
Front Barnett Associates's Pfizer position peaked at $709K in Q4 2021.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Front Barnett Associates's 13F filing for Q3 2023, filed 13 Nov 2023.